Relation between androgen hormone with sexual function in women use LD

Not Applicable

• Conditions: female sexual dysfunction.; Behavioural syndromes associated with physiological disturbances and physical factors; F50-F59

• Registration Number: IRCT2013070213846N1
• Lead Sponsor: Vice chancellor for Research, Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 89

Inclusion Criteria

willingness to participate; married woman with age between 18-35 years old; having score 28 or more of Female Sexual Function Index; not pregnant; not having breast feeding; no history of heart disease and vascular disease (the patient's medical records); no history of uncontrolled hypertension and hypotension; no history of liver dysfunction; not taking any medications that affect sexual function (specially common antidepressant); not having migraine and ulcer; don’t use alcohol and cigarette; not sexual function disorder; regular mensturation.
Exclusion criteria : taking hormone pills particulary OCP; taking alchohl or tobacco; history of active peptic ulcer disease ; history of headaches including migraines; history of dysparunia or vaginismus.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Female sexual dysfunction. Timepoint: At the start of intervention- After 3 months of intervention. Method of measurement: Female Sexual Function Index Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Improvement of sexual function. Timepoint: At the start of intervention- After 3 months of intervention. Method of measurement: Female Sexual Function Index Questionnaire.